About Dermata Therapeutics, Inc. - Common Stock (DRMA)
Dermata Therapeutics Inc is a biotechnology company focused on developing innovative therapeutics for skin diseases and conditions. The company leverages its proprietary technology platform to create treatments that aim to improve patient outcomes in dermatology. Dermata Therapeutics is committed to addressing unmet medical needs and advancing its product candidates through various stages of clinical development. By prioritizing research and development, the company seeks to bring forward effective solutions for skin health and enhance the quality of life for individuals affected by dermatological disorders. Read More
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
SAN DIEGO, CA / ACCESS Newswire / December 4, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a science-driven leader in dermatologic solutions, today announced that it will soon reveal its new brand name for its over-the-counter ("OTC") skincare business representing its evolution toward a more direct, science-first era of dermatologic innovation. While the name remains confidential until the formal unveiling, the Company is offering a first look at the mission and essence driving this new identity-one created specifically for the community of skincare consumers who expect more from their products, their science, and the companies behind them.
